Search research articles
Contact Us
Filters
Showing results (1-10 of 93) with videos related to
Page
of 10
Sort By:
Advances in Experimental Medicine and Biology
|
December 17, 2020
Cannabinoid-Based Medicines and Multiple Sclerosis
Clementina Manera, Simone Bertini
Recent Patents on CNS Drug Discovery
|
May 20, 2016
Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders
Clementina Manera, Chiara Arena, Andrea Chicca
Molecules (Basel, Switzerland)
|
June 26, 2026
Bridging Discovery, Mechanism, and Application: An Integrated Strategy for Bioactive Natural Products
Tao Liu, Clementina Manera, Francesca Gado
Mini Reviews in Medicinal Chemistry
|
May 14, 2008
Indoles and related compounds as cannabinoid ligands
Clementina Manera, Tiziano Tuccinardi, Adriano Martinelli
Recent Patents on CNS Drug Discovery
|
September 16, 2016
Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Andrea Chicca, Chiara Arena, Clementina Manera
Neuropharmacology
|
January 15, 2021
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice
Lindsey Shapiro, Francesca Gado, Clementina Manera, et al.
Medicines (Basel, Switzerland)
|
August 17, 2018
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
Francesca Gado, Maria Digiacomo, Marco Macchia, et al.
European Journal of Medicinal Chemistry
|
January 24, 2006
Adenosine receptor modelling. A1/A2a selectivity
Tiziano Tuccinardi, Gabriella Ortore, Clementina Manera, et al.
Nuclear Medicine and Biology
|
July 9, 2010
Microfluidic approach for fast labeling optimization and dose-on-demand implementation
Giancarlo Pascali, Grazia Mazzone, Giuseppe Saccomanni, et al.
Current Medicinal Chemistry
|
March 25, 2021
Phenolic Compounds in Prevention and Treatment of Skin Cancers: A Review
Francesca Gado, Maria Digiacomo, Jasmine Esposito Salsano, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 93) with videos related to
Sort By:
Page
of 10
Advances in Experimental Medicine and Biology
|
December 17, 2020
Cannabinoid-Based Medicines and Multiple Sclerosis
Clementina Manera, Simone Bertini
Recent Patents on CNS Drug Discovery
|
May 20, 2016
Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders
Clementina Manera, Chiara Arena, Andrea Chicca
Molecules (Basel, Switzerland)
|
June 26, 2026
Bridging Discovery, Mechanism, and Application: An Integrated Strategy for Bioactive Natural Products
Tao Liu, Clementina Manera, Francesca Gado
Mini Reviews in Medicinal Chemistry
|
May 14, 2008
Indoles and related compounds as cannabinoid ligands
Clementina Manera, Tiziano Tuccinardi, Adriano Martinelli
Recent Patents on CNS Drug Discovery
|
September 16, 2016
Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Andrea Chicca, Chiara Arena, Clementina Manera
Neuropharmacology
|
January 15, 2021
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice
Lindsey Shapiro, Francesca Gado, Clementina Manera, et al.
Medicines (Basel, Switzerland)
|
August 17, 2018
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
Francesca Gado, Maria Digiacomo, Marco Macchia, et al.
European Journal of Medicinal Chemistry
|
January 24, 2006
Adenosine receptor modelling. A1/A2a selectivity
Tiziano Tuccinardi, Gabriella Ortore, Clementina Manera, et al.
Nuclear Medicine and Biology
|
July 9, 2010
Microfluidic approach for fast labeling optimization and dose-on-demand implementation
Giancarlo Pascali, Grazia Mazzone, Giuseppe Saccomanni, et al.
Current Medicinal Chemistry
|
March 25, 2021
Phenolic Compounds in Prevention and Treatment of Skin Cancers: A Review
Francesca Gado, Maria Digiacomo, Jasmine Esposito Salsano, et al.
Page
of 10